Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11790470 | 1.00 | MPI (0.48) | MPIAKR1B1PTPN1 | |
| SCHEMBL7152900 | 1.00 | MPI (0.48) | MPIAKR1B1PTPN1 | |
| SCHEMBL177758 | 0.89 | MPI (0.46) | MPIAKR1B1PTPN1 | |
| SCHEMBL7148553 | 0.89 | MPI (0.46) | MPIAKR1B1PTPN1 | |
| SCHEMBL1922060 | 0.89 | MPI (0.46) | MPIAKR1B1PTPN1 | |
| SCHEMBL5972505 | 0.89 | MPI (0.46) | MPIAKR1B1PTPN1 | |
| SCHEMBL4601534 | 0.89 | MPI (0.46) | MPIAKR1B1PTPN1 | |
| SCHEMBL9737340 | 0.85 | MPI (0.40) | MPIAKR1B1PTPN1 | |
| SCHEMBL9738005 | 0.85 | MPI (0.40) | MPIAKR1B1PTPN1 | |
| SCHEMBL9737690 | 0.85 | MPI (0.40) | MPIAKR1B1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111527211-B | Microorganism producing mycosporine-like amino acid and method for producing mycosporine-like amino acid using the same | CJ第一制糖株式会社 | 2023-12-01 | — | — | CN | disclosed |
| EP-3670661-B1 | MICROORGANISM PRODUCING MYCOSPORINE-LIKE AMINO ACID AND MICOSPORINE-LIKE AMINO ACID PRODUCTION METHOD USING SAME | CJ CHEILJEDANG CORP (KR) | 2023-11-01 | — | — | EP | disclosed |
| EP-3754024-A1 | MYCOSPORINE-LIKE AMINO ACID-PRODUCING MICROORGANISM AND METHOD FOR PRODUCTION OF MYCOSPORINE-LIKE AMINO ACIDS BY USING SAME | CJ Cheiljedang Corporation (KR) | 2020-12-23 | — | — | EP | disclosed |
| CN-111527211-A | Microorganism producing mycosporine-like amino acid and method for producing mycosporine-like amino acid using the same | CJ第一制糖株式会社 | 2020-08-11 | — | — | CN | disclosed |
| EP-3670661-A1 | MICROORGANISM PRODUCING MYCOSPORINE-LIKE AMINO ACID AND MICOSPORINE-LIKE AMINO ACID PRODUCTION METHOD USING SAME | CJ Cheiljedang Corporation (KR) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019035612-A1 | MICROORGANISM PRODUCING MYCOSPORINE-LIKE AMINO ACID AND MICOSPORINE-LIKE AMINO ACID PRODUCTION METHOD USING SAME | 씨제이제일제당 (주) | 2019-02-21 | — | — | WO | disclosed |
| US-9938451-B2 | Enhanced electrolytic degradation of controlled electrolytic material | BAKER HUGHES, A GE COMPANY, LLC (US) | 2018-04-10 | — | — | US | disclosed |
| US-9534243-B2 | Nucleotide analogs and process for making same enzyme | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE (US) | 2017-01-03 | — | — | US | disclosed |
| US-20160009986-A1 | ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL | BAKER HUGHES INCORPORATED (US) | 2016-01-14 | — | — | US | disclosed |
| US-9187686-B2 | Enhanced electrolytic degradation of controlled electrolytic material | BAKER HUGHES INCORPORATED (US) | 2015-11-17 | — | — | US | disclosed |
| WO-2013070419-A1 | ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL | BAKER HUGHES INCORPORATED (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130112429-A1 | ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL | BAKER HUGHES INCORPORATED (US) | 2013-05-09 | — | — | US | disclosed |
| WO-2010014817-A2 | PRODUCING FERMENTATION PRODUCTS | NOVOZYMES A/S (DK) | 2010-02-04 | — | — | WO | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
| US-3948883-A | Synthesis of purine nucleosides | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | MPI 841/4885AKR1B1 1482/4885PTPN1 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.